Desuden bør patienter advares om risikoen for hypoglykæmi, når Janumet anvendes sammen med andre sulfonylurinstoffer.
In addition, patients should be alerted to the risk of hypoglycaemia when Janumet is used in combination with other sulfonylurea agents.